- Home
- PMVP vs VNRX Comparison
PMVP vs VNRX Comparison
Compare PMVP & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- VNRX
- Stock Information
- Founded
- PMVP 2013
- VNRX N/A
- Country
- PMVP United States
- VNRX United States
- Employees
- PMVP N/A
- VNRX N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PMVP Health Care
- VNRX Health Care
- Exchange
- PMVP Nasdaq
- VNRX Nasdaq
- Market Cap
- PMVP 76.8M
- VNRX 69.7M
- IPO Year
- PMVP 2020
- VNRX N/A
- Fundamental
- Price
- PMVP $1.42
- VNRX $0.65
- Analyst Decision
- PMVP Strong Buy
- VNRX Strong Buy
- Analyst Count
- PMVP 1
- VNRX 4
- Target Price
- PMVP $5.00
- VNRX $3.50
- AVG Volume (30 Days)
- PMVP 949.9K
- VNRX 213.9K
- Earning Date
- PMVP 11-06-2025
- VNRX 11-13-2025
- Dividend Yield
- PMVP N/A
- VNRX N/A
- EPS Growth
- PMVP N/A
- VNRX N/A
- EPS
- PMVP N/A
- VNRX N/A
- Revenue
- PMVP N/A
- VNRX $1,319,252.00
- Revenue This Year
- PMVP N/A
- VNRX $324.32
- Revenue Next Year
- PMVP N/A
- VNRX $247.82
- P/E Ratio
- PMVP N/A
- VNRX N/A
- Revenue Growth
- PMVP N/A
- VNRX 35.10
- 52 Week Low
- PMVP $0.81
- VNRX $0.40
- 52 Week High
- PMVP $1.84
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- PMVP 50.54
- VNRX N/A
- Support Level
- PMVP $1.36
- VNRX N/A
- Resistance Level
- PMVP $1.49
- VNRX N/A
- Average True Range (ATR)
- PMVP 0.08
- VNRX 0.00
- MACD
- PMVP 0.01
- VNRX 0.00
- Stochastic Oscillator
- PMVP 57.41
- VNRX 0.00
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.